0001062993-22-020875.txt : 20221017 0001062993-22-020875.hdr.sgml : 20221017 20221017171828 ACCESSION NUMBER: 0001062993-22-020875 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221017 FILED AS OF DATE: 20221017 DATE AS OF CHANGE: 20221017 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ENLOE J DAVID JR CENTRAL INDEX KEY: 0001201526 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36329 FILM NUMBER: 221314339 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Societal CDMO, Inc. CENTRAL INDEX KEY: 0001588972 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261523233 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 E. UWCHLAN AVE, SUITE 112 CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 770-534-8239 MAIL ADDRESS: STREET 1: 1 E. UWCHLAN AVE, SUITE 112 CITY: EXTON STATE: PA ZIP: 19341 FORMER COMPANY: FORMER CONFORMED NAME: Recro Pharma, Inc. DATE OF NAME CHANGE: 20131010 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2022-10-17 0001588972 Societal CDMO, Inc. SCTL 0001201526 ENLOE J DAVID JR C/O SOCIETAL CDMO, INC. 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341 1 1 0 0 Chief Executive Officer Common Stock 2022-10-17 4 P 0 625 1.69 A 508808 D This transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Ryan D. Lake, attorney-in-fact 2022-10-17